Auron Therapeutics, Inc. Email Format
Biotechnology ResearchMassachusetts, United States11-50 Employees
Auron Therapeutics, Inc. is a privately held biotechnology company focused on oncology, based in Newton, Massachusetts. It adopts a platform-driven approach to develop therapies that address cell-state plasticity, with pipelines aimed at treating solid tumors and hematological malignancies. The firm highlights AURIGIN as its framework for identifying the drivers of tumor plasticity and the altered cellular states that underlie cancer, guiding the development of targeted, small-molecule therapies. Its work centers on oncology patients and the clinicians and researchers who treat them, aiming to improve outcomes by addressing cellular-state changes that fuel cancer progression. As a clinical-stage company, Auron Therapeutics advances therapies for both solid tumors and blood cancers, and has engaged in public scientific discourse, such as presenting data from a Small Cell Lung Cancer meeting in New York in April 2025.